Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-01-04
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Evaluation of Pitaya Ovule Extract on Skin
NCT05311020
Efficacy Testing of Chenopodium Formosanum Extracts on Skin Beauty
NCT05591352
Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin
NCT06854419
Efficacy Evaluation of Wasabi Leaf Extract on Skin
NCT05310994
RCT for the Chinese Medicine in Treating Hypercholesterolemia
NCT06700408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo drink
Placebo drink
consume 1 bottle (50 mL) per day for 8 weeks
Dai Dai flower drink
Dai Dai flower drink
consume 1 bottle (50 mL) per day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo drink
consume 1 bottle (50 mL) per day for 8 weeks
Dai Dai flower drink
consume 1 bottle (50 mL) per day for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) ≥ 24 (kg/m\^2) or body fat mass ≥ 25%
Exclusion Criteria
* Implementation in weight loss programs, consumption drugs or supplements for weight control before 3 months of this study
* Participate weight control or fat loss human studies before 3 months of this study
* History of cardiovascular disease, liver disease, kidney disease, endocrine disease, or other major organic diseases (according to subjects reporting).
* Person who has received major surgery or bariatric surgery (according to medical history).
* Person who has received constant drug use.
* People with mental illness
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hsiu-Mei Chiang, Prof.
Role: PRINCIPAL_INVESTIGATOR
China Medical University, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China Medical University
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH109-REC1-161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.